Improve walking balance and attention
- Trial ID
- NCT06444685
- Official Title
- Motor and Cognitive Effects of Table Tennis on Parkinson's Disease: Pilot Controlled Trial
- Goal
- Improve walking balance and attention
- Phase
- NA
- Status
- RECRUITING
- Sponsor
- Universitat de Lleida
- Study Type
- INTERVENTIONAL
- Enrollment
- 20 participants
- Conditions
- Parkinson Disease
- Interventions
- Exercise and cognitive training interventino
Plain-Language Summary
It tests whether regular table tennis can improve motor problems like balance, walking, and arm control, while also helping thinking skills such as attention, reaction time, and multitasking in people with early to mid-stage Parkinson's. The approach uses guided table tennis sessions that combine aerobic movement, repetitive arm and trunk use, hand-eye coordination, and fast decision making, activities that may boost motor control and cognitive processing through practice and increased brain blood flow, and it is meant to add to, not replace, usual medications like levodopa. The trial is looking for people aged 40 to 80 with Parkinson's at Hoehn and Yahr stages I to III who can walk 10 minutes unassisted, and excludes those with significant cognitive impairment (MMSE < 23), major vision or hearing loss, serious cardiac limits to exercise, or prior brain surgery.
Locations
- Institut de Recerca Biomèdica de Lleida, Lleida, Spain
Frequently Asked Questions
- What is this trial testing?
- This trial is studying Exercise and cognitive training interventino. It tests whether regular table tennis can improve motor problems like balance, walking, and arm control, while also helping thinking skills such as attention, reaction time, and multitasking in people with early to mid-stage Parkinson's. The approach uses guided table tennis sessions that combine aerobic movement, repetitive arm and trunk use, hand-eye coordination, and fast decision making, activities that may boost motor control and cognitive processing through practice and increased brain blood flow, and it is meant to add to, not replace, usual medications like levodopa. The trial is looking for people aged 40 to 80 with Parkinson's at Hoehn and Yahr stages I to III who can walk 10 minutes unassisted, and excludes those with significant cognitive impairment (MMSE < 23), major vision or hearing loss, serious cardiac limits to exercise, or prior brain surgery.
- Who can participate?
- Participants must be between 40 Years and 80 Years.
- Where is this trial located?
- This trial is recruiting at 1 location.
- Does it cost anything to join?
- No. There is no cost to participate. Study-related care and treatment are provided at no charge.
- How long does the trial last?
- This trial is estimated to last approximately 1 year and 9 months.